The largest database of trusted experimental protocols

Human neurology 3 plex a assay

Manufactured by Quanterix
Sourced in United States

The Human Neurology 3-Plex A assay is a multiplex assay that measures three biomarkers related to neurological conditions. The assay is designed to quantify the levels of these biomarkers in biological samples. The core function of the assay is to provide accurate and reliable measurements of the selected biomarkers.

Automatically generated - may contain errors

2 protocols using human neurology 3 plex a assay

1

Alzheimer's Disease Biomarkers in Chinese

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human population sample (n = 1419) was derived from participants in the baseline survey of the MIND-China,19 (link) a participating project of the World-Wide FINGERS Network.26 (link) AD was diagnosed according to the National Institute of Aging-Alzheimer's Association (NIA-AA) criteria,27 (link) for probable AD, as previously reported.28 (link) Multiple-PCR amplification analysis of genomic DNA was performed for participants to detect KIBRA gene Single Nucleotide Polymorphism (SNP) risk loci and exon region.29 Plasma total-tau, Aβ40, and Aβ42 levels were measured on a Simoa platform (Quanterix Corp, MA, USA) with Human Neurology 3-Plex A assay (N3PA), following the manufacturer's instructions.23 (link)
+ Open protocol
+ Expand
2

Quantification of Plasma Biomarkers

Check if the same lab product or an alternative is used in the 5 most similar protocols
After an overnight fast, peripheral blood samples were drawn into ethylene diamine tetraacetic acid (EDTA) citrate vacutainer tubes and centrifuged in a tabletop centrifuge. Plasma samples were then aliquoted and stored at −80°C until being retrieved and thawed on ice. Plasma biomarkers were measured using the single‐molecule array (Simoa) platform (Quanterix Corp, MA, USA) for Aβ42, Aβ40, and total tau (Human Neurology 3‐Plex A assay), and NfL (NF‐light advantage kit) at the laboratory of Wayen Biotechnologies Inc., Shanghai, China. Two quality control plasma samples were run in duplicate on each plate for each analyte. The intra‐assay coefficient of variation and the interassay coefficient of variation were all below 13.0% for the control sample.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!